Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lisa D. Curcio"'
Autor:
Edward D. Esplin, Sadia Khan, Barry P. Rosen, Robert L. Nussbaum, Linsey Gold, Linda Ann Smith, Michael Kinney, Patricia Clark, Gia Compagnoni, Rache M. Simmons, Sam Lyons, Dennis R. Holmes, Cynara Coomer, Shan Yang, Mary Kay Hardwick, Heather MacDonald, Karen Barbosa, Peter D. Beitsch, Eric J. Brown, Lisa D. Curcio, Pat Whitworth, Paul L. Baron, Ian Grady, Kevin S. Hughes, Rakesh Patel, Lee B. Riley, Tony Ruiz
Publikováno v:
Cancer Research. 80:P6-08
Background: HBOC testing guidelines were established to identify patients with clinically actionable variants and limit economic burden. We report the impact of germline results on health outcome based on clinical decision making and treatment interv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7959e4d173e13193707e2beb27878ce2
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-28
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-28
Autor:
Ed D. Esplin, Linda Ann Smith, Michael Kinney, Patricia Clark, Eric J. Brown, Samuel Lyons, Sadia Kahn, Lisa D. Curcio, P Baron, Linsey Gold, Gia Compagnoni, Dennis R. Holmes, Peter D. Beitsch, Antonio Carlos Sánchez Ruiz, Pat Whitworth, Rakesh R. Patel, Mary Kay Hardwick, Ian Grady, Robert L. Nussbaum, Lee Riley, Cynara Coomer, Shan Yang, Barry Rosen, Heather MacDonald, Karen Barbosa, Rache M. Simmons, Kevin S. Hughes
Publikováno v:
Journal of Clinical Oncology
Purpose An estimated 10% of breast and ovarian cancers result from hereditary causes. Current testing guidelines for germ line susceptibility genes in patients with breast carcinoma were developed to identify carriers of BRCA1/ 2 variants and have ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc8624c949fda3182c2a9f3551f14b5
https://doi.org/10.1200/jco.18.01631
https://doi.org/10.1200/jco.18.01631
Autor:
Peter D. Beitsch, S Lyons, Linsey Gold, Barry P. Rosen, Rakesh Patel, Dennis R. Holmes, Shan Yang, Antonio Carlos Sánchez Ruiz, Rache M. Simmons, Michael Kinney, Heather MacDonald, Patricia Clark, Karen Barbosa, Linda Ann Smith, Cynara Coomer, S Kahn, P Baron, Edward D. Esplin, Eric J. Brown, Lisa D. Curcio, Gia Compagnoni, P Whitworth, Ian Grady, Lee B. Riley
Publikováno v:
Cancer Research. 79:P5-09
Background: Pathogenic genetic variants are estimated to occur in 10-15% of all breast cancer patients, with BRCA 1/2 accounting for 40-50% of pathogenic/likely pathogenic (P/LP) variants. However, it is estimated that Methods: An IRB-approved multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46237eaf96e1f72349289e1c8ce0996
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-06
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-06
Autor:
Dennis R. Holmes, Antonio Carlos Sánchez Ruiz, Eric J. Brown, Rache M. Simmons, Shan Yang, Linda Ann Smith, Cynara Coomer, Lisa D. Curcio, Heather MacDonald, Barry P. Rosen, Karen Barbosa, Peter D. Beitsch, Gia Compagnoni, P Whitworth, Ian Grady, Edward D. Esplin, Lee B. Riley, Linsey Gold, S Kahn, S Lyons, Rakesh Patel, Scott T. Michalski, Michael Kinney, Patricia Clark, P Baron
Publikováno v:
Cancer Research. 79:P5-09
Background: The testing of hereditary breast and ovarian cancer (HBOC) patients for BRCA1/2 only was established years ago to identify patients with clinically actionable variants and limit the economic burden. However, the cost of genetic testing ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f56568c60b35b83494cbfde725b4eb2d
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-03
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-03
Autor:
Kenneth R Tomkovich, Susan A Seedman, Richard E. Fine, Susan K. Boolbol, Sheldon Feldman, Lydia Hernandez, Jill R. Dietz, Lisa D. Curcio, Karen S Columbus, Linda K Han, Andrew S Kenler, Michael S. Sabel, Eric R. Manahan, Rache M. Simmons, Margaret Chen, Richard C. Gilmore, Linsey Gold, Rashmi P Vaidya, Alexander B Sevrukov, Hussein D Aoun, Randy D Hicks, Noam A VanderWalde, Michael P Berry
Publikováno v:
Annals of surgical oncology. 28(10)
The ICE3 trial is designed to evaluate the safety and efficacy of breast cryoablation, enabling women older than 60 years with low-risk early-stage breast cancers to benefit from a nonsurgical treatment and to avoid the associated surgical risks. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64da15f8ef71682d2597278c512a094f
https://pubmed.ncbi.nlm.nih.gov/34392462
https://pubmed.ncbi.nlm.nih.gov/34392462
Autor:
Michael S. Sabel, Karen S Columbus, Michael P Berry, Noam A VanderWalde, Susan K. Boolbol, Linda K Han, Linsey Gold, Hussein D Aoun, Kenneth R Tomkovich, Margaret Chen, Lydia Hernandez, Jill R. Dietz, Susan A Seedman, Alexander B Sevrukov, Randy D Hicks, Eric R. Manahan, Rache M. Simmons, Sheldon Feldman, Andrew S Kenler, Lisa D. Curcio, Richard E. Fine, Richard C. Gilmore, Rashmi P Vaidya
Publikováno v:
Annals of Surgical Oncology. 28:628-629
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d67c7eb204820dcc32506f71cae7eb19
https://doi.org/10.1245/s10434-021-10618-6
https://doi.org/10.1245/s10434-021-10618-6
Autor:
Lucy Chittenden, Rajesh K. Khanijou, Jane L. Kakkis, Jessica Lizarde, John Ravera, Jorge C. Macedo, Albert V. Mesa, Jeffrey Agustin, Richard B. Wilder, Martin E. Eisner, Lisa D. Curcio, Kenneth M. Tokita
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 78:799-803
Purpose: To report our results with accelerated partial breast irradiation (APBI) in terms of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2/neu) status. Methods and Materials: Between February
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88639ba92f87431b67352ffddb4b12c
https://doi.org/10.1016/j.ijrobp.2009.08.081
https://doi.org/10.1016/j.ijrobp.2009.08.081
Autor:
Martin E. Eisner, Rajesh K. Khanijou, Richard B. Wilder, Jeffrey Agustin, Jane L. Kakkis, John Ravera, Kenneth M. Tokita, Albert V. Mesa, Lucy Chittenden, Jorge C. Macedo, Lisa D. Curcio, Jessica Lizarde
Publikováno v:
The Breast Journal. 16:581-586
The objective of this study was to report our single-institution results with MammoSite and multi-catheter brachytherapy. Between February 2003 and January 2009, 173 women with unifocal pathological Tis, T1, or T2 (up to 30 mm), N0 or N1 carcinomas o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f8a5e9b1994e9d347623dc1faef811c
https://doi.org/10.1111/j.1524-4741.2010.00977.x
https://doi.org/10.1111/j.1524-4741.2010.00977.x
Autor:
John G. West, Rachel E. McFarland, Carlee A. Blakemore, Lisa D. Curcio, Amy K. Bremner, Nimmi S. Kapoor, Kimberly C. Banks
Publikováno v:
Annals of surgical oncology. 22(10)
Recently introduced multigene panel testing including BRCA1 and BRCA2 genes for hereditary cancer risk has raised concerns with the ability to detect all deleterious BRCA1/2 mutations compared to older methods of sequentially testing BRCA1/2 separate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8907a34945b9bf1413f64ca508e688ed
https://pubmed.ncbi.nlm.nih.gov/26219241
https://pubmed.ncbi.nlm.nih.gov/26219241
Autor:
George Somlo, Ken Clarke, Elizabeth Rupp, Wydell L. Williams, David Chu, Tamara Odom-Maryon, Lisa D. Curcio, Joshua D. I. Ellenhorn, Lawrence D. Wagman
Publikováno v:
Annals of Surgical Oncology. 6:249-254
Inflammatory breast cancer is a locally advanced tumor with an aggressive local and systemic course. Treatment of this disease has been evolving over the last several decades. The aim of this study was to assess whether current therapies, both surgic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ae873c17b3a9a945fdf8eeb23cbfb6
https://doi.org/10.1007/s10434-999-0249-3
https://doi.org/10.1007/s10434-999-0249-3